Literature DB >> 18537584

The guinea pig as an animal model for asthma.

Fabio L M Ricciardolo1, Frans Nijkamp, Virginia De Rose, Gert Folkerts.   

Abstract

Experimental guinea pig asthma is a reliable and clinically relevant facsimile of human disease. The guinea pig is the preferred choice for use as a model of allergic bronchial asthma in the evaluation of anti-asthmatic drugs, since the airway anatomy and the response to inflammatory mediators is similar to humans. Further, the great strength of this model is the direct anaphylactic bronchoconstriction upon antigen challenge. Under certain conditions a late asthmatic response can be measured and airway hyperresponsiveness is observed in vitro and in vivo. Moreover, the inflammatory response is comparable with the human situation. More recent studies describe a chronic model for asthma in which airway remodeling is induced as can be observed in the asthmatic patients. The focus here is to demonstrate that guinea pig asthma models are useful for testing novel therapeutics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18537584     DOI: 10.2174/138945008784533534

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  16 in total

1.  Aerosolized polymerized type I collagen reduces airway inflammation and remodelling in a guinea pig model of allergic asthma.

Authors:  Paola Moreno-Alvarez; Edgar Sánchez-Guerrero; Erasmo Martínez-Cordero; Rogelio Hernández-Pando; María G Campos; Lucely Cetina; Blanca Bazán-Perkins
Journal:  Lung       Date:  2009-12-09       Impact factor: 2.584

2.  MAG-EPA and 17,18-EpETE target cytoplasmic signalling pathways to reduce short-term airway hyperresponsiveness.

Authors:  Rayan Khaddaj-Mallat; Éric Rousseau
Journal:  Pflugers Arch       Date:  2014-08-13       Impact factor: 3.657

3.  PGE2 maintains the tone of the guinea pig trachea through a balance between activation of contractile EP1 receptors and relaxant EP2 receptors.

Authors:  J Säfholm; S-E Dahlén; I Delin; K Maxey; K Stark; L-O Cardell; M Adner
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

4.  An optimized five-color/seven-parameter flow cytometry panel for immunophenotyping guinea pig peripheral blood lymphocytes.

Authors:  John V Stokes; Anna E Crawford; Claire E Cross; Anne-Marie L Ross; Jamie D Walker; Bridget V Willeford; Andrea S Varela-Stokes
Journal:  J Immunol Methods       Date:  2019-11-01       Impact factor: 2.303

Review 5.  Barriers to inhaled gene therapy of obstructive lung diseases: A review.

Authors:  Namho Kim; Gregg A Duncan; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2016-05-16       Impact factor: 9.776

6.  Understanding asthma using animal models.

Authors:  Yoo Seob Shin; Katsuyuki Takeda; Erwin W Gelfand
Journal:  Allergy Asthma Immunol Res       Date:  2009-09-25       Impact factor: 5.764

7.  Relaxant effect of ghrelin on guinea pig isolated tracheal smooth muscle: role of epithelial NO and PGE2.

Authors:  Mohammed Saeed Zayed Al-Ayed
Journal:  Pflugers Arch       Date:  2018-02-26       Impact factor: 3.657

8.  Cranial Vena Cava Syndrome in Guinea Pigs with Chronic Jugular Vein Catheters.

Authors:  Timothy K Cooper; Russell A Byrum; Kurt Cooper; Lisa Evans DeWald; Nina M Aiosa; Irwin M Feuerstein; Marisa C St Claire
Journal:  Comp Med       Date:  2020-01-16       Impact factor: 0.982

Review 9.  Animal Models Reflecting Chronic Obstructive Pulmonary Disease and Related Respiratory Disorders: Translating Pre-Clinical Data into Clinical Relevance.

Authors:  Lloyd Tanner; Andrew Bruce Single
Journal:  J Innate Immun       Date:  2019-09-17       Impact factor: 7.349

Review 10.  The guinea pig model for tick-borne spotted fever rickettsioses: A second look.

Authors:  John V Stokes; David H Walker; Andrea S Varela-Stokes
Journal:  Ticks Tick Borne Dis       Date:  2020-08-07       Impact factor: 3.744

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.